Andy Bass
Keine laufenden Positionen mehr
Profil
Andy Bass is the founder of Biological & Popular Culture, Inc. Prior to founding the company, he worked as the Director of Business Development at Cellectis, Inc. and as the Senior Vice President of the Consumer Sector at Precigen, Inc. He received his undergraduate degree from The University of Alabama at Birmingham.
Ehemalige bekannte Positionen von Andy Bass
Unternehmen | Position | Ende |
---|---|---|
Biological & Popular Culture, Inc.
Biological & Popular Culture, Inc. Home FurnishingsConsumer Durables Biological & Popular Culture, Inc. manufactures fine and decorative artworks, accessories and toys. The company was founded by Dean Sauer and Andy Bass and is headquartered in Carlsbad, CA. | Vorstandsvorsitzender | - |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Corporate Officer/Principal | - |
PRECIGEN, INC. | Corporate Officer/Principal | - |
Ausbildung von Andy Bass
The University of Alabama at Birmingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Biological & Popular Culture, Inc.
Biological & Popular Culture, Inc. Home FurnishingsConsumer Durables Biological & Popular Culture, Inc. manufactures fine and decorative artworks, accessories and toys. The company was founded by Dean Sauer and Andy Bass and is headquartered in Carlsbad, CA. | Consumer Durables |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |